Evaluation of the efficacy and safety of avapritnib in a real-life series of patients diagnosed with gastrointestinal stromal tumor (GIST), with PDGFRA D842V mutation with locally advanced or metastatic disease, treated with avapritinib
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: PRIVATE FOUNDATION OF THE VALL D'HEBRON ONCOLOGY RESEARCH INSTITUTE
- Execution start: 26/09/2023
- End of execution: 30/04/2024
- IP: JUAN RAMON DELGADO PEREZ